Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Fernández Guinea, Oscar ^a   Andicoechea, Alejandro ^a   González, Luis O ^a,b   González Reyes, Salomé ^a,b   Merino, Antonio M ^c   Hernández, Luis C ^d   López Muñiz, Alfonso ^d   García Pravia, Paz ^a   Vizoso, Francisco J ^a,b  

^a HOSPITAL DE JOVE   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL DE CABUEÑES   (Spain)

^d UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; ERBB2 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CONTRAST ENHANCEMENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; TUMOR VOLUME; BIOSYNTHESIS; BREAST TUMOR; GENE EXPRESSION REGULATION; KINETICS; METHODOLOGY; MICROCIRCULATION; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; KINETICS; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 76849103369     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-8     Document Type: Article

References (31)

1. Orel SG, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble BL, Torosian MH, Rosato EF. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995, 196:115-122.
2. Liberman L. Breast MR imaging in assessing extent of disease. Magn Reson Imaging Clin N Am 2006, 14:339-349. 10.1016/j.mric.2006.07.007, 17098175.
3. Kuhl C. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 2007, 244:672-691. 10.1148/radiol.2443051661, 17709824.
4. Boetes C, Barentsz JO, Mus RD, Sluis RF, van Erning LJ, Hendriks JH, Holland R, Ruys SH. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994, 193:777-781.
5. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999, 211:101-110.
6. Padhani AR, Hayes C, Assersohn L, Powles T, Makris A, Suckling J, Leach MO, Husband JE. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 2006, 239:361-374. 10.1148/radiol.2392021099, 16543585.
7. Hylton N. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn Reson Imaging Clin N Am 2006, 14:383-389. 10.1016/j.mric.2006.09.001, 17098179.
8. Bone B, Szabo BK, Perbeck LG, Veress B, Aspelin P. Can contrast-enhanced MR imaging predict survival in breast cancer?. Acta Radiol 2003, 44:373-378.
9. Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O, Kudo S. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000, 217:841-848.
10. Tuncbilek N, Karakas HM, Okten OO. Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. Eur J Radiol 2005, 53:199-205. 10.1016/j.ejrad.2003.11.004, 15664283.
11. Hara T, Miyazaki H, Lee A, Tran CP, Reiter RE. Androgen receptor and invasion in prostate cancer. Cancer Res 2008, 68:1128-1135. 10.1158/0008-5472.CAN-07-1929, 18281488.
12. Montemurro F, Martincich L, Sarotto I, Bertotto I, Ponzone R, Cellini L, Redana S, Sismondi P, Aglietta M, Regge D. Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer. Eur Radiol 2007, 17:1490-1497. 10.1007/s00330-006-0505-x, 17149623.
13. Dixon AR, Ellis IO, Elston CW, Blamey RW. A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast. Br J Cancer 1991, 63:634-635. 1972371, 1850613.
14. Liu N, Lapcevich RK, Underhill CB, Han Z, Gao F, Swartz G, Plum SM, Zhang L, Green SJ. Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth. Cancer Res 2001, 61:1022-1028.
15. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11:155-168.
16. BI-RADS American College of Radiology. Breast imaging reporting and data system. 2003, Reston, VA: American College of Radiology, 4, BI-RADS.
17. Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995, 197:387-395.
18. Fischer U, Kopka L, Brinck U, Korabiowska M, Schauer A, Grabbe E. Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. Eur Radiol 1997, 7:1002-1005. 10.1007/s003300050240, 9265662.
19. Lee SH, Cho N, Kim SJ, Cha JH, Cho KS, Ko ES, Moon WK. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol 2008, 9:10-18. 10.3348/kjr.2008.9.1.10, 2627175, 18253071.
20. Gilchrist KW, Kalish L, Gould VE, Hirschl S, Imbriglia JE, Levy WM, Patchefsky AS, Penner DW, Pickren J, Roth JA, et al. Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study. Breast Cancer Res Treat 1985, 5:3-10. 10.1007/BF01807642, 3978246.
21. Elledge RM, McGuire WL, Osborne CK. Prognostic factors in breast cancer. Semin Oncol 1992, 19:244-253.
22. Bone B, Aspelin P, Bronge L, Veress B. Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 1998, 39:279-284.
23. Frouge C, Guinebretiere JM, Contesso G, Di Paola R, Blery M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994, 29:1043-1049. 10.1097/00004424-199412000-00006, 7536719.
24. Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003, 13:2425-2435. 10.1007/s00330-003-2000-y, 12898176.
25. Teifke A, Behr O, Schmidt M, Victor A, Vomweg TW, Thelen M, Lehr HA. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. Radiology 2006, 239:351-360. 10.1148/radiol.2392050205, 16569783.
26. Kuhl CK, Schild HH. Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging 2000, 12:965-974. 10.1002/1522-2586(200012)12:6<965::AID-JMRI23>3.0.CO;2-1, 11105038.
27. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005, 69(Suppl 3):4-10. 10.1159/000088478, 16301830.
28. Stomper PC, Herman S, Klippenstein DL, Winston JS, Budnick RM, Stewart CC. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. Cancer 1996, 77:1844-1849. 10.1002/(SICI)1097-0142(19960501)77:9<1844::AID-CNCR13>3.0.CO;2-#, 8646683.
29. Lin EY, Pollard JW. Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 2004, 90:2053-2058. 10.1038/sj.bjc.6601705, 2410285, 15164120.
30. Adams TE, Alpert S, Hanahan D. Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic beta cells. Nature 1987, 325:223-228. 10.1038/325223a0, 3543686.
31. Gonzalez LO, Pidal I, Junquera S, Corte MD, Vazquez J, Rodriguez JC, Lamelas ML, Merino AM, Garcia-Muniz JL, Vizoso FJ. Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse. Br J Cancer 2007, 97:957-963. 10.1038/sj.bjc.6603935, 2360420, 17848954.